Skip to main content
. Author manuscript; available in PMC: 2009 Sep 8.
Published in final edited form as: J Thorac Cardiovasc Surg. 2008 Aug;136(2):452–461. doi: 10.1016/j.jtcvs.2007.12.036

Table 2.

Type of ventricular support required by 119 ventricular dysfunction (VnD) patients after primary CABG surgery

Type of Ventricular Support Number and % of VnD patients
Intraoperative Postoperative
2 inotropes 57 (47.9%) 46 (38.7%)
≥ 3 inotropes 9 (7.6%) 24 (20.2%)
IABP insertion time 19 (16.0%) 12 (10.1%)
VAD insertion time 0 (0%) 1 (0.8%)
Inotrope
Amrinone 2 (1.7%) 2 (1.7%)
Milrinone 14 (11.8%) 19 (16.0%)
Dobutamine 6 (5.0%) 6 (5.0%)
Isoproterenol 1 (0.8%) 2 (1.7%)
Dopamine (>5mcg/kg/min) 19 (16.0%) 16 (13.4%)
Epinephrine 87 (73.1%) 75 (63.0%)
Norepinephrine 39 (32.8%) 42 (35.3%)
Vasopressin 9 (7.6%) 40 (33.6%)

IABP indicates intra-aortic balloon pump; VAD indicates ventricular assist device